Gastric cancer
Conditions
Interventions
Gold Standard:Pathological results serve as the gold standard
Index test:Low-depth whole-genome sequencing
Sponsors
Suzhou Xiangcheng People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed with gastric cancer; 2. Age 18 – 75 years old; 3. Blood samples can be provided for cfDNA testing; 4. Voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Suffering from severe hepatic and renal insufficiency, hematologic diseases, or other diseases that may affect cfDNA levels; 2. Received chemotherapy, radiotherapy, blood transfusion or other treatments that may affect cfDNA levels within the past 3 months; 3. Unable to provide qualified blood samples; 4. Combined with other malignant tumors (within 5 years) or active infection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cfDNA fragmentomics features;Model performance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinicopathological characteristics; | — |
Countries
China
Contacts
Public ContactLian Lian
Suzhou Xiangcheng People's Hospital
Outcome results
None listed